{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:18Z","timestamp":1793944878646,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Santelys Association"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4102-6","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T19:03:01Z","timestamp":1518462181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study"],"prefix":"10.1186","volume":"18","author":[{"given":"Cecile","family":"Olivier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Grosbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis B.","family":"Cortot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Delourme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Gierczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hoorelbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-1863","authenticated-orcid":false,"given":"Arnaud","family":"Scherpereel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Le Rouzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"4102_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of Pemetrexed in combination with Cisplatin versus Cisplatin alone in patients with malignant pleural Mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"4102_CR2","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387:1405\u201314.","journal-title":"Lancet"},{"key":"4102_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejon.2010.01.003","volume":"14","author":"S Akin","year":"2010","unstructured":"Akin S, Can G, Aydiner A, Ozdilli K, Durna Z. Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 2010;14:400\u20139.","journal-title":"Eur J Oncol Nurs"},{"key":"4102_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.lungcan.2013.11.014","volume":"83","author":"CL Granger","year":"2014","unstructured":"Granger CL, McDonald CF, Irving L, Clark RA, Gough K, Murnane A, et al. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer. 2014;83:292\u20139.","journal-title":"Lung Cancer"},{"key":"4102_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/JTO.0b013e31819e77e8","volume":"4","author":"G Kasymjanova","year":"2009","unstructured":"Kasymjanova G, Correa JA, Kreisman H, Dajczman E, Pepe C, Dobson S, et al. Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol. 2009;4:602\u20137.","journal-title":"J Thorac Oncol"},{"key":"4102_CR6","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","volume":"188","author":"MA Spruit","year":"2013","unstructured":"Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society\/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"4102_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pneumo.2012.11.003","volume":"69","author":"J-M Grosbois","year":"2013","unstructured":"Grosbois J-M, Le Rouzic O, Monge E, Bart F, Wallaert B. Comparison of home-based and outpatient, hospital-based, pulmonary rehabilitation in patients with chronic respiratory diseases. Rev Pneumol Clin. 2013;69:10\u20137.","journal-title":"Rev Pneumol Clin"},{"key":"4102_CR8","first-page":"2037","volume":"10","author":"JM Grosbois","year":"2015","unstructured":"Grosbois JM, Gicquello A, Langlois C, Le Rouzic O, Bart F, Wallaert B, Chenivesse C. Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2037\u201344.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"4102_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/JTO.0000000000000536","volume":"10","author":"BC Bade","year":"2015","unstructured":"Bade BC, Thomas DD, Scott JB, Silvestri GA. Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol. 2015;10:861\u201371.","journal-title":"J Thorac Oncol"},{"key":"4102_CR10","doi-asserted-by":"crossref","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u20137.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"4102_CR11","first-page":"657","volume":"11","author":"J Grosbois","year":"2016","unstructured":"Grosbois J, Riquier C, Chehere B, Coquart J, B\u00e9hal H, Bart F, et al. Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis. 2016;11:657\u201363.","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"4102_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/HCR.0b013e3182773fae","volume":"33","author":"RN Bellet","year":"2013","unstructured":"Bellet RN, Francis RL, Jacob JS, Healy KM, Bartlett HJ, Adams L, et al. Timed up and go tests in cardiac rehabilitation: reliability and comparison with the 6-minute walk test. J Cardiopulm Rehabil Prev. 2013;33:99\u2013105.","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"4102_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/thoraxjnl-2013-203576","volume":"68","author":"SE Jones","year":"2013","unstructured":"Jones SE, Kon SSC, Canavan JL, Patel MS, Clark AL, Nolan CM, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax. 2013;68:1015\u201320.","journal-title":"Thorax"},{"key":"4102_CR14","first-page":"377","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"4102_CR15","first-page":"9","volume":"4","author":"T Perez","year":"2009","unstructured":"Perez T, Arnould B, Grosbois J-M, Bosch V, Guillemin I, Bravo M-L, et al. Validity, reliability, and responsiveness of a new short visual simplified respiratory questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009;4:9\u201318.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4102_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"4102_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0140-6736(85)92589-9","volume":"326","author":"JP Lepine","year":"1985","unstructured":"Lepine JP, Godchau M, Brun P. Anxiety and depression in inpatients. Lancet. 1985;326:1425\u20136.","journal-title":"Lancet"},{"key":"4102_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1479972310393756","volume":"8","author":"A Keating","year":"2011","unstructured":"Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8:89\u201399.","journal-title":"Chron Respir Dis"},{"key":"4102_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/thoraxjnl-2013-204227","volume":"69","author":"SE Jones","year":"2014","unstructured":"Jones SE, Green SA, Clark AL, Dickson MJ, Nolan A-M, Moloney C, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014;69:181\u20132.","journal-title":"Thorax"},{"key":"4102_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.lungcan.2011.07.006","volume":"75","author":"M Quist","year":"2012","unstructured":"Quist M, R\u00f8rth M, Langer S, Jones LW, Laursen JH, Pappot H, et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012;75:203\u20138.","journal-title":"Lung Cancer"},{"key":"4102_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1249\/MSS.0000000000000158","volume":"46","author":"L Kuehr","year":"2014","unstructured":"Kuehr L, Wiskemann J, Abel U, Ulrich CM, Hummler S, Thomas M. Exercise in patients with non-small cell lung cancer. Med Sci Sports Exerc. 2014;46:656\u201363.","journal-title":"Med Sci Sports Exerc"},{"key":"4102_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00520-013-1925-1","volume":"22","author":"CC Henke","year":"2014","unstructured":"Henke CC, Cabri J, Fricke L, Pankow W, Kandilakis G, Feyer PC, et al. Strength and endurance training in the treatment of lung cancer patients in stages IIIA\/IIIB\/IV. Support. Care cancer off. J Multinatl Assoc Support Care Cancer. 2014;22:95\u2013101.","journal-title":"J Multinatl Assoc Support Care Cancer"},{"key":"4102_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jpainsymman.2012.05.006","volume":"45","author":"AL Cheville","year":"2013","unstructured":"Cheville AL, Kollasch J, Vandenberg J, Shen T, Grothey A, Gamble G, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manag. 2013;45:811\u201321.","journal-title":"J Pain Symptom Manag"},{"key":"4102_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.rmed.2012.11.016","volume":"107","author":"C Hayton","year":"2013","unstructured":"Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107:401\u20137.","journal-title":"Respir Med"},{"key":"4102_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.apmr.2016.08.459","volume":"98","author":"AL Cheville","year":"2017","unstructured":"Cheville AL, Rhudy L, Basford JR, Griffin JM, Flores AM. How receptive are patients with late stage cancer to rehabilitation services and what are the sources of their resistance? Arch Phys Med Rehabil. 2017;98:203\u201310.","journal-title":"Arch Phys Med Rehabil"},{"key":"4102_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative Care for Patients with metastatic non\u2013small-cell lung cancer. N Engl J Med. 2010;363:733\u201342.","journal-title":"N Engl J Med"},{"key":"4102_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00520-013-2080-4","volume":"22","author":"W Jensen","year":"2014","unstructured":"Jensen W, Bialy L, Ketels G, Baumann FT, Bokemeyer C, Oechsle K. Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysis. Support. Care cancer off. J. Multinatl. Assoc. Support. Care Cancer. 2014;22:1261\u20138.","journal-title":"J. Multinatl. Assoc. Support. Care Cancer"},{"key":"4102_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.lungcan.2011.10.009","volume":"76","author":"LW Jones","year":"2012","unstructured":"Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer Amst Neth. 2012;76:248\u201352.","journal-title":"Lung Cancer Amst Neth"},{"key":"4102_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/NCC.0000000000000176","volume":"38","author":"Y-Y Lin","year":"2015","unstructured":"Lin Y-Y, Liu MF, Tzeng J-I, Lin C-C. Effects of walking on quality of life among lung cancer patients: a longitudinal study. Cancer Nurs. 2015;38:253\u20139.","journal-title":"Cancer Nurs"},{"key":"4102_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lungcan.2016.06.018","volume":"99","author":"SM Shallwani","year":"2016","unstructured":"Shallwani SM, Simmonds MJ, Kasymjanova G, Spahija J. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data. Lung Cancer. 2016;99:69\u201375.","journal-title":"Lung Cancer"},{"key":"4102_CR31","first-page":"595","volume":"4","author":"JS Temel","year":"2009","unstructured":"Temel JS, Greer JA, Goldberg S, Vogel PD, Sullivan M, Pirl WF, et al. A structured exercise program for patients with advanced non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2009;4:595\u2013601.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"4102_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4081\/oncol.2014.245","volume":"8","author":"JA Tang","year":"2014","unstructured":"Tang JA, Oh T, Scheer JK, Parsa AT. The current trend of administering a patient-generated index in the Oncological setting: a systematic review. Oncol Rev. 2014;8:245.","journal-title":"Oncol Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4102-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T19:26:00Z","timestamp":1549999560000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4102-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4102"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4102-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"1 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the observational research protocol evaluation committee of the French Language Society of Pulmonology (CEPRO 2011\u2013036 \u2013 Comit\u00e9 d\u2019Evaluation des Protocoles de Recherche Observationnels of the Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise). All patients were informed and included after providing written consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Olivier reports non-financial support from Actelion, ALK, AstraZeneca, Bayer, Boehringer Ingelheim, Elia Medical, Janssen-Cilag, GlaxoSmithKline, LFB biomedicaments, Lilly, Mundipharma, Novartis, Pfizer, Pharma Dom, Pierre Fabre Medicament, Roche, Vertex and Zambon, outside the submitted work.Dr. Grosbois reports non-financial support from Actelion, ADS Lorraine, AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, Fresenius Kabi, Intermune, GlaxoSmithKline, LFB biomedicaments, LVL Medical, MSD, Mundipharma, Novartis, Pfizer, Pharma Dom, Pierre Fabre Medicament, Preciphar, Roche, Santelys Association, Santeo, Takeda, Teva, Vitalaire and Zambon, outside the submitted work, received financial support from Adair, France Oxyg\u00e8ne, Homeperf, LVL, Orkyn, Sant\u00e9lys, Santeo, SOS Oxyg\u00e8ne, Sysmed, VitalAire and the ARS Nord Pas de Calais for home-based PR program and being an employee of FormAction Sante.Pr. Cortot reports non-financial support from ALK, AstraZeneca, Boehringer Ingelheim, Bristol-Myers, Chiesi, Chugai Pharma, Hospira, Icomed, Kephren, GlaxoSmithKline, LEO Pharma, Lilly, Medexact, MSD, Mundipharma, Novartis, Pfizer, Roche, SOS Oxygene and Stallergenes, outside the submitted work.Dr. Peres reports being an employee of Santelys Association.Mr. Heron reports non-financial support from Perf Nut Assistance Nord, outside the submitted work.Dr. Delourme reports non-financial support from Aeris Medical, Aeris Sante, Allergan, Bayer, Boehringer Ingelheim, CSL Behring, GlaxoSmithKline, Medexact, MSD, Novartis, Pierre Fabre Medicament and Vitalaire, outside the submitted work.Ms. Gierczynski reports non-financial support from Bristol-Myers, outside the submitted work.Dr. Hoorelbeke reports having been an employee of Santelys Association.Pr. Scherpereel reports non-financial support from Amgen, Bayer, Janssen-Cilag, Pierre Fabre Medicament, Roche, Santelys Association, TEVA; and personal fees for experts boards and non-financial support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squib, MSD, and Roche.Dr. Le Rouzic reports non-financial support from AstraZeneca, Chiesi, GlaxoSmithKline, LEO Pharma, MSD, Mundipharma, Santelys Association, Teva and Vitalaire, and personal fees and non-financial support from Boehringer Ingelheim, Lilly and Novartis, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"178"}}